Michael Parris - 30 Sep 2023 Form 4 Insider Report for WRAP TECHNOLOGIES, INC. (WRAP)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
19 Oct 2023, 16:32:55 UTC
Prior SEC filing
10 Jul 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Chris DeAlmeida, Attorney-in-Fact

Key filing fact

Michael Parris filed Form 4 for WRAP TECHNOLOGIES, INC. (WRAP) on 19 Oct 2023.

Key facts

  • This page summarizes Michael Parris's Form 4 filing for WRAP TECHNOLOGIES, INC. (WRAP).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 19 Oct 2023, 16:32.

Change

  • Previous filing in this sequence was filed on 10 Jul 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

WRAP transaction

Common Stock

Award

Transaction value
Shares
+10,083
Change %
+3.6%
Price
Shares after
287,611
Date
30 Sep 2023
Ownership
Direct
Footnotes
F1
WRAP transaction

Common Stock

Award

Transaction value
Shares
+21,607
Change %
+7.5%
Price
Shares after
309,218
Date
12 Oct 2023
Ownership
Direct
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Michael Parris is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

Represents shares of Restricted Stock (the "Shares") issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended September 30, 2023. The number of Shares was calculated based on the amount due the Reporting Person at the end of the quarter, or $15,125, divided by the closing price of the Company's Common Stock on such date. 30% of the Shares were vested as of the date of the grant, with the remainder vesting ratably in eight monthly tranches beginning November 1, 2023.

Footnote F2

Represents shares of Restricted Stock issued in connection with the Reporting Person's resignation from the Issuer's Board of Directors.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .